CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy Chairman and CEO bought 52,600 shares at an average $0.40 ($21,225)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Chairman and CEO bought 27,500 shares at an average $0.44 ($11,975)
- 4 Open-market buy Chairman and CEO bought 69,400 shares at an average $0.28 ($19,288)
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Chairman and CEO bought 65,000 shares at an average $0.17 ($11,300)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Chairman and CEO bought 45,000 shares at an average $0.19 ($8,700)
- 4 Open-market buy Chairman and CEO bought 97,500 shares at an average $0.18 ($17,200)
- 4 Open-market buy Chairman and CEO bought 165,000 shares at an average $0.08 ($13,250)
- 4 Open-market buy Chairman and CEO bought 185,000 shares at an average $0.11 ($20,370)
Page 5 of 63 · 1,250 filings